OpenURL Connection Search

Select item for more details and to access through your institution.

Long Prime–Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine.
Published in:
Vaccines, 2024, v. 12, n. 6, p. 587, doi. 10.3390/vaccines12060587
By:
- Cheung, Irene Y.;
- Mauguen, Audrey;
- Modak, Shakeel;
- Basu, Ellen M.;
- Feng, Yi;
- Kushner, Brian H.;
- Cheung, Nai Kong
Publication type:
Article
Stage 4N neuroblastoma before and during the era of anti‐GD2 immunotherapy.
Published in:
International Journal of Cancer, 2023, v. 153, n. 12, p. 2019, doi. 10.1002/ijc.34693
By:
- Kushner, Brian H.;
- LaQuaglia, Michael P.;
- Cardenas, Fiorella Iglesias;
- Basu, Ellen M.;
- Gerstle, Justin T.;
- Kramer, Kim;
- Roberts, Stephen S.;
- Wolden, Suzanne L.;
- Cheung, Nai‐Kong V.;
- Modak, Shakeel
Publication type:
Article
Immunotherapy with anti‐GD2 monoclonal antibody in infants with high‐risk neuroblastoma.
Published in:
International Journal of Cancer, 2023, v. 152, n. 2, p. 259, doi. 10.1002/ijc.34233
By:
- Kushner, Brian H.;
- Modak, Shakeel;
- Kramer, Kim;
- Basu, Ellen M.;
- Iglesias‐Cardenas, Fiorella;
- Roberts, Stephen S.;
- Cheung, Nai‐Kong V.
Publication type:
Article
Treatment and outcome of adult‐onset neuroblastoma.
Published in:
International Journal of Cancer, 2018, v. 143, n. 5, p. 1249, doi. 10.1002/ijc.31399
By:
- Suzuki, Maya;
- Kushner, Brian H.;
- Kramer, Kim;
- Basu, Ellen M.;
- Roberts, Stephen S.;
- Hammond, William J.;
- LaQuaglia, Michael P.;
- Wolden, Suzanne L.;
- Cheung, Nai‐Kong V.;
- Modak, Shakeel
Publication type:
Article
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.
Published in:
International Journal of Cancer, 2017, v. 140, n. 2, p. 480, doi. 10.1002/ijc.30440
By:
- Kushner, Brian H.;
- Cheung, Nai‐Kong V.;
- Modak, Shakeel;
- Becher, Oren J.;
- Basu, Ellen M.;
- Roberts, Stephen S.;
- Kramer, Kim;
- Dunkel, Ira J.
Publication type:
Article
Ovarian function in female survivors of high‐risk neuroblastoma.
Published in:
Pediatric Blood & Cancer, 2024, v. 71, n. 9, p. 1, doi. 10.1002/pbc.31181
By:
- Jimenez‐Kurlander, Lauren;
- DeRosa, Amelia;
- Kostrzewa, Caroline E.;
- Moskowitz, Chaya S.;
- Bogardus, Kimberly;
- Antal, Zoltan;
- Wolden, Suzanne;
- La Quaglia, Michael P.;
- Basu, Ellen M.;
- Cardenas, Fiorella Iglesias;
- Kramer, Kim;
- Kushner, Brian H.;
- Cheung, Nai‐Kong V.;
- Modak, Shakeel;
- Friedman, Danielle Novetsky
Publication type:
Article
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.
Published in:
Pediatric Blood & Cancer, 2023, v. 70, n. 2, p. 1, doi. 10.1002/pbc.30075
By:
- Tringale, Kathryn R.;
- Wolden, Suzanne L.;
- Casey, Dana L.;
- Kushner, Brian H.;
- Luo, Leo;
- Pandit‐Taskar, Neeta;
- Souweidane, Mark;
- Cheung, Nai‐Kong V.;
- Modak, Shakeel;
- Basu, Ellen M.;
- Kramer, Kim
Publication type:
Article
Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma.
Published in:
2021
By:
- Shahid, Sanam;
- Kushner, Brian H.;
- Modak, Shakeel;
- Basu, Ellen M.;
- Rubin, Elyssa M.;
- Gundem, Gunes;
- Papaemmanuil, Elli;
- Roberts, Stephen S.
Publication type:
journal article
Reduced‐dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
Published in:
Pediatric Blood & Cancer, 2020, v. 67, n. 9, p. 1, doi. 10.1002/pbc.28364
By:
- Luo, Leo Y.;
- Kramer, Kim;
- Cheung, Nai‐Kong V.;
- Kushner, Brian H.;
- Modak, Shakeel;
- Basu, Ellen M.;
- Roberts, Stephen S.;
- Wolden, Suzanne L.
Publication type:
Article
Treatment and revaccination of children with paraneoplastic opsoclonus‐myoclonus‐ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.
Published in:
Pediatric Blood & Cancer, 2020, v. 67, n. 8, p. 1, doi. 10.1002/pbc.28319
By:
- Patel, Ami;
- Fischer, Cheryl;
- Lin, Yi‐Chih;
- Basu, Ellen M.;
- Kushner, Brian H.;
- De Braganca, Kevin;
- Khakoo, Yasmin
Publication type:
Article
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
Published in:
2020
By:
- Luo, Leo Y;
- Kramer, Kim;
- Cheung, Nai-Kong V;
- Kushner, Brian H;
- Modak, Shakeel;
- Basu, Ellen M;
- Roberts, Stephen S;
- Wolden, Suzanne L
Publication type:
journal article
Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.
Published in:
2020
By:
- Patel, Ami;
- Fischer, Cheryl;
- Lin, Yi-Chih;
- Basu, Ellen M;
- Kushner, Brian H;
- De Braganca, Kevin;
- Khakoo, Yasmin
Publication type:
journal article
Osteochondroma in long-term survivors of high-risk neuroblastoma.
Published in:
Cancer (0008543X), 2015, v. 121, n. 12, p. 2090, doi. 10.1002/cncr.29316
By:
- Kushner, Brian H.;
- Roberts, Stephen S.;
- Friedman, Danielle N.;
- Kuk, Deborah;
- Ostrovnaya, Irina;
- Modak, Shakeel;
- Kramer, Kim;
- Basu, Ellen M.;
- Cheung, Nai‐Kong V.
Publication type:
Article
Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.
Published in:
Cancer (0008543X), 2014, v. 120, n. 13, p. 2050, doi. 10.1002/cncr.28687
By:
- Kushner, Brian H.;
- Modak, Shakeel;
- Kramer, Kim;
- LaQuaglia, Michael P.;
- Yataghene, Karima;
- Basu, Ellen M.;
- Roberts, Stephen S.;
- Cheung, Nai‐Kong V.
Publication type:
Article
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.
Published in:
2013
By:
- Kushner, Brian H;
- Modak, Shakeel;
- Basu, Ellen M;
- Roberts, Stephen S;
- Kramer, Kim;
- Cheung, Nai-Kong V
Publication type:
journal article
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.
Published in:
Cancer (0008543X), 2013, v. 119, n. 15, p. 2789, doi. 10.1002/cncr.28137
By:
- Kushner, Brian H.;
- Modak, Shakeel;
- Basu, Ellen M.;
- Roberts, Stephen S.;
- Kramer, Kim;
- Cheung, Nai‐Kong V.
Publication type:
Article
Ifosfamide, carboplatin, and etoposide for neuroblastoma.
Published in:
Cancer (0008543X), 2013, v. 119, n. 3, p. 665, doi. 10.1002/cncr.27783
By:
- Kushner, Brian H.;
- Modak, Shakeel;
- Kramer, Kim;
- Basu, Ellen M.;
- Roberts, Stephen S.;
- Cheung, Nai‐Kong V.
Publication type:
Article
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.
Published in:
Journal of Neuro-Oncology, 2023, v. 162, n. 1, p. 69, doi. 10.1007/s11060-022-04235-w
By:
- Tringale, Kathryn R.;
- Wolden, Suzanne L.;
- Karajannis, Matthias;
- Haque, Sofia;
- Pasquini, Luca;
- Yildirim, Onur;
- Rosenblum, Marc;
- Benhamida, Jamal K.;
- Cheung, Nai-Kong;
- Souweidane, Mark;
- Basu, Ellen M.;
- Pandit-Taskar, Neeta;
- Zanzonico, Pat B.;
- Humm, John L.;
- Kramer, Kim
Publication type:
Article
Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease.
Published in:
Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1106597
By:
- Fong, Christina;
- Kushner, Brian H.;
- Di Giannatale, Angela;
- Gundem, Gunes;
- Li, Shanita;
- Roberts, Stephen S.;
- Basu, Ellen M.;
- Price, Anita;
- Cheung, Nai-Kong V.;
- Modak, Shakeel
Publication type:
Article
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
Published in:
Neuro-Oncology, 2022, v. 24, p. 1776, doi. 10.1093/neuonc/noac087
By:
- Desai, Ami V;
- Robinson, Giles W;
- Gauvain, Karen;
- Basu, Ellen M;
- Macy, Margaret E;
- Maese, Luke;
- Whipple, Nicholas S;
- Sabnis, Amit J;
- Foster, Jennifer H;
- Shusterman, Suzanne;
- Yoon, Janet;
- Weiss, Brian D;
- Abdelbaki, Mohamed S;
- Armstrong, Amy E;
- Cash, Thomas;
- Pratilas, Christine A;
- Corradini, Nadège;
- Marshall, Lynley V;
- Farid-Kapadia, Mufiza;
- Chohan, Saibah
Publication type:
Article

Found: 20

Long Prime–Boost Interval and Heightened Anti-GD2 Antibody Response to Carbohydrate Cancer Vaccine.

Stage 4N neuroblastoma before and during the era of anti‐G<sub>D2</sub> immunotherapy.

Immunotherapy with anti‐G<sub>D2</sub> monoclonal antibody in infants with high‐risk neuroblastoma.

Treatment and outcome of adult‐onset neuroblastoma.

A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.

Ovarian function in female survivors of high‐risk neuroblastoma.

Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.

Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma.

Reduced‐dose craniospinal irradiation for central nervous system relapsed neuroblastoma.

Treatment and revaccination of children with paraneoplastic opsoclonus‐myoclonus‐ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.

Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.

Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.

Osteochondroma in long-term survivors of high-risk neuroblastoma.

Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-G<sub>D2</sub> 3F8 monoclonal antibody.

Ifosfamide, carboplatin, and etoposide for neuroblastoma.

Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.

Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease.

Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).